160 related articles for article (PubMed ID: 15368926)
1. [Modern therapy of COPD].
Pariente R; Aubier M
Bull Acad Natl Med; 2004; 188(1):67-74; discussion 74-5. PubMed ID: 15368926
[TBL] [Abstract][Full Text] [Related]
2. [Selective phosphodiesterase 4 inhibition. Controlling inflammation--also in patients with COPD].
MMW Fortschr Med; 2004 Apr; 146(18):59. PubMed ID: 15366479
[No Abstract] [Full Text] [Related]
3. Phosphodiesterase inhibitors in airways disease.
Fan Chung K
Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
[TBL] [Abstract][Full Text] [Related]
4. Selective phosphodiesterase 4 inhibitors in the treatment of allergy and inflammation.
Smith VB; Spina D
Curr Opin Investig Drugs; 2005 Nov; 6(11):1136-41. PubMed ID: 16312135
[TBL] [Abstract][Full Text] [Related]
5. [Inflammatory lung and systemic disease].
Med Monatsschr Pharm; 2005 Jul; 28(7):254-5. PubMed ID: 16038131
[No Abstract] [Full Text] [Related]
6. [Selective phosphodiesterase-4 (PDE-4) inhibitors in COPD].
Tatlicioğlu T
Tuberk Toraks; 2008; 56(4):472-84. PubMed ID: 19123088
[TBL] [Abstract][Full Text] [Related]
7. Agents against cytokine synthesis or receptors.
Yamagata T; Ichinose M
Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic benefit of PDE4 inhibitors in inflammatory diseases.
Dastidar SG; Rajagopal D; Ray A
Curr Opin Investig Drugs; 2007 May; 8(5):364-72. PubMed ID: 17520865
[TBL] [Abstract][Full Text] [Related]
9. Roflumilast for the treatment of chronic obstructive pulmonary disease.
Antoniu SA
Curr Opin Investig Drugs; 2006 May; 7(5):412-7. PubMed ID: 16729716
[TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterase-4: selective and dual-specificity inhibitors for the therapy of chronic obstructive pulmonary disease.
Giembycz MA
Proc Am Thorac Soc; 2005; 2(4):326-33; discussion 340-1. PubMed ID: 16267357
[TBL] [Abstract][Full Text] [Related]
11. AWD-12-281 (inhaled) (elbion/GlaxoSmithKline).
Gutke HJ; Guse JH; Khobzaoui M; Renukappa-Gutke T; Burnet M
Curr Opin Investig Drugs; 2005 Nov; 6(11):1149-58. PubMed ID: 16312137
[TBL] [Abstract][Full Text] [Related]
12. COPD, inflammation and its modulation by phosphodiesterase 4 inhibitors: time to look beyond the FEV1.
Celli B
Chest; 2006 Jan; 129(1):5-6. PubMed ID: 16424403
[No Abstract] [Full Text] [Related]
13. CC-10004 .
Khobzaoui M; Gutke HJ; Burnet M
Curr Opin Investig Drugs; 2005 May; 6(5):518-25. PubMed ID: 15912967
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase 4 inhibitors: antiinflammatory therapy for chronic obstructive pulmonary disease at last?
Kerstjens HA; Timens W
Am J Respir Crit Care Med; 2003 Oct; 168(8):914-5. PubMed ID: 14555456
[No Abstract] [Full Text] [Related]
15. [Phosphosdiesterase 4 inhibitors in the treatment of pulmonary diseases].
Xia XD; Dai YR; Xu ZJ
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jan; 27(1):57-9. PubMed ID: 14989829
[No Abstract] [Full Text] [Related]
16. Are phosphodiesterase 4 inhibitors just more theophylline?
Boswell-Smith V; Cazzola M; Page CP
J Allergy Clin Immunol; 2006 Jun; 117(6):1237-43. PubMed ID: 16750981
[TBL] [Abstract][Full Text] [Related]
17. Type 4 phosphodiesterase-dependent pathways: role in inflammatory processes.
Jacob C; Martin-Chouly C; Lagente V
Therapie; 2002; 57(2):163-8. PubMed ID: 12185965
[TBL] [Abstract][Full Text] [Related]
18. Chronic obstructive pulmonary disease, inflammation and PDE4 inhibitors.
Halpin DM
Br J Hosp Med (Lond); 2006 Jul; 67(7):370-4. PubMed ID: 16884152
[No Abstract] [Full Text] [Related]
19. The potential role of roflumilast: the new phosphodiesterase-4 inhibitor.
Karish SB; Gagnon JM
Ann Pharmacother; 2006 Jun; 40(6):1096-104. PubMed ID: 16735669
[TBL] [Abstract][Full Text] [Related]
20. Cilomilast: orally active selective phosphodiesterase-4 inhibitor for treatment of chronic obstructive pulmonary disease.
Martina SD; Ismail MS; Vesta KS
Ann Pharmacother; 2006 Oct; 40(10):1822-8. PubMed ID: 16985092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
